Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Scorpius Holdings Inc SCPX

Scorpius Holdings, Inc. is a contract development and manufacturing organization (CDMO) that provides process development and biomanufacturing services to support the biomanufacturing needs of third parties who use its biomanufacturing capacity as a fee-for-service model through its subsidiary, Scorpius Biomanufacturing, Inc. The Company couples Current Good Manufacturing Practices (CGMP) biomanufacturing and quality control knowledge with capabilities in immunoassays, molecular assays, and bioanalytical methods to support cell- and gene-based therapies as well as large molecule biologics using American-made equipment, reagents, and materials. It offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. The Company's CDMO service offerings also include enhanced microbial and mammalian development and manufacturing services.


NYSEAM:SCPX - Post by User

Comment by DenmarkandHuxion Mar 19, 2019 4:20am
129 Views
Post# 29504352

RE:bottoming out at these levels

RE:bottoming out at these levelsThink the chinese will intervene within short. If the results in Q2 are good certainly!!

<< Previous
Bullboard Posts
Next >>